Literature DB >> 33651852

Combined pre- and post-capillary pulmonary hypertension: The clinical implications for patients with heart failure.

Tatsuro Ibe1, Hiroshi Wada1, Kenichi Sakakura1, Yusuke Ugata1, Hisataka Maki1, Kei Yamamoto1, Masaru Seguchi1, Yousuke Taniguchi1, Hiroyuki Jinnouchi1, Shin-Ichi Momomura1, Hideo Fujita1.   

Abstract

BACKGROUND: The prognostic implications of combined pre- and post-capillary pulmonary hypertension (Cpc-PH) in patients with pulmonary hypertension due to left heart disease (PH-LHD) remain controversial. The aim of this retrospective study was to evaluate the new PH-LHD criteria, recommended by the 6th World Symposium on Pulmonary Hypertension and to determine the prognostic value of Cpc-PH.
METHODS: A total of 701 patients with symptomatic heart failure who had undergone right-heart catheterization were divided into the following four groups: (i) Isolated post-capillary PH (Ipc-PH) group; mean pulmonary artery pressure (mPAP) >20 mmHg, pulmonary artery wedge pressure (PAWP) >15 mmHg, and pulmonary vascular resistance (PVR) <3 Wood units (WU) (ii) Cpc-PH group; mPAP >20 mmHg, PAWP >15 mmHg, and PVR ≥3 WU (iii) borderline-PH group; mPAP >20 mmHg and PAWP ≤15 mmHg (iv) non-PH group; mPAP ≤20 mmHg. Multivariate Cox hazard analysis was used to investigate whether Cpc-PH was associated with cardiac outcomes.
RESULTS: The study subjects were allocated into the Ipc-PH (n = 268), Cpc-PH (n = 54), borderline-PH (n = 112), or non-PH (n = 267) groups. The Cpc-PH group was associated significantly with adverse cardiac events even after adjustment for clinically relevant confounding factors for heart failure prognosis (vs. non-PH group: HR 2.98 [95% CI 1.81-4.90], P <0.001; vs. Ipc-PH group: HR: 1.92 [95% CI 1.19-3.08], P = 0.007).
CONCLUSIONS: The new definitions of PH-LHD stratified patients into 4 categories. Long-term clinical outcomes were significantly different between the four categories, with Cpc-PH having the worst cardiac outcomes.

Entities:  

Year:  2021        PMID: 33651852     DOI: 10.1371/journal.pone.0247987

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  5 in total

Review 1.  Future perspective in diabetic patients with pre- and post-capillary pulmonary hypertension.

Authors:  Federico Luongo; Cristiano Miotti; Gianmarco Scoccia; Silvia Papa; Giovanna Manzi; Nadia Cedrone; Federica Toto; Claudia Malerba; Gennaro Papa; Annalisa Caputo; Giulia Manguso; Francesca Adamo; Dario Vizza Carmine; Roberto Badagliacca
Journal:  Heart Fail Rev       Date:  2022-01-31       Impact factor: 4.214

2.  Unloading the right to fill the left: vasodilation to treat hypotension: a case report.

Authors:  Fatima M Ezzeddine; Melanie C Bois; Barry A Borlaug
Journal:  Eur Heart J Case Rep       Date:  2022-04-23

3.  Measurement of Pulmonary Artery Wave Reflection Before and After Mitral Valvuloplasty in Canine Patients With Pulmonary Hypertension Caused by Myxomatous Mitral Valve Disease.

Authors:  Tomohiko Yoshida; Kazumi Shimada; Lina Hamabe; Tsuyoshi Uchide; Ryou Tanaka; Katsuhiro Matsuura
Journal:  Front Vet Sci       Date:  2021-12-02

Review 4.  Acute and chronic exercise training in patients with Class II pulmonary hypertension: effects on haemodynamics and symptoms.

Authors:  Mattia Lunardi; Sijing Wu; Patrick W Serruys; Yoshinobu Onuma; Osama Soliman; William Wijns; Wilfried Mullens; Faisal Sharif
Journal:  ESC Heart Fail       Date:  2022-02-07

Review 5.  Animal models of pulmonary hypertension due to left heart disease.

Authors:  Shao-Fei Liu; Yi Yan
Journal:  Animal Model Exp Med       Date:  2022-02-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.